Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Adult Bipolar Mania [Phase 4]
This document reports a Phase 4 clinical trial update for adults with acute mania associated with bipolar disorder; results were posted afte…
-
CLINICAL_TRIALS trial_result · 2012-04-10Clinical Trial Update: Quetiapine XR Versus Sertraline in Acute Bipolar Depression as add-on Therapy [Phase 3]
Phase 3 head-to-head trial comparing quetiapine XR added to antidepressant therapy versus sertraline in adults with acute bipolar depression…
-
CLINICAL_TRIALS trial_result · 2012-04-10Clinical Trial Update: Study of the Broad Clinical Benefit for Seroquel XR With Flexible Dose as an add-on Therapy in the Treatment of Acute Bipolar Mania Patients With Partial Response to Current Therapy [Phase 4]
Phase 4 study evaluating Seroquel XR as add-on therapy for acute bipolar mania with partial response; the trial was terminated and results w…
-
CLINICAL_TRIALS trial_result · 2012-04-09Clinical Trial Update: Sleep Deprivation and Advancement of Sleep Period as Treatment for Bipolar Depression. [NA]
A clinical trial evaluating sleep deprivation with adjusted sleep timing as a treatment for bipolar depression has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-04-06Clinical Trial Update: Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar Disorder [Phase 4]
A Phase 4 trial evaluated quetiapine for mania in preschool children aged 4 to 6 with bipolar disorder, and the results were posted in 2012.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-04-06Clinical Trial Update: Lamotrigine for the Treatment of Mania in Youth Ages 6-17 With Bipolar Disorder [Phase 4]
Phase 4 clinical trial update evaluating lamotrigine for treating mania in youths aged 6-17 with bipolar disorder; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2012-04-06Clinical Trial Update: Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents [Phase 4]
Phase 4 trial evaluating omega-3 fatty acids as an add-on to open-label aripiprazole for pediatric bipolar disorder. The study was terminate…
-
CLINICAL_TRIALS trial_result · 2012-04-03Clinical Trial Update: Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance Abuse [Phase 4]
Phase 4 clinical trial evaluating pregnenolone for depression in individuals with bipolar disorder or recurrent major depressive disorder wi…
-
FDA approval · 2012-03-27FDA Approved: LAMOTRIGINE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for a Lamotrigine product from Unichem Pharmaceuticals (USA), Inc., effectively approving a gene…
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's generic quetiapine tablets through an Original Application. Quetiapine is approved for schizophrenia, bipolar disorder, …
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE — Original Application (Accord Healthcare Inc.)
FDA approved a generic Quetiapine product from Accord Healthcare Inc. under ANDA202152 (Original Application).
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved the original application for a generic version of quetiapine fumarate from Sun Pharmaceutical Industries.
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s original-application generic quetiapine fumarate, a generic version of the antipsychotic queti…
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (BluePoint Laboratories)
FDA approved the original application for quetiapine fumarate as a generic drug, with BluePoint Laboratories listed as the applicant.
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s generic quetiapine fumarate (ANDA 090120) via an Original Application approval. The generic is…
-
FDA approval · 2012-03-27FDA Approved: QUETIAPINE FUMARATE — Original Application (Aurobindo Pharma Limited)
The FDA approved an original application for a generic quetiapine fumarate from Aurobindo Pharma Limited. This adds a generic option for the…
-
FDA approval · 2012-03-26FDA Approved: LAMOTRIGINE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for lamotrigine from Glenmark Pharmaceuticals (ANDA 079099).
-
FDA approval · 2012-03-22FDA Approved: ZIPRASIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for ZIPRASIDONE submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2012-03-20FDA Approved: OLANZAPINE — Supplemental Application (American Regent, Inc.)
FDA approved a supplemental application for olanzapine from American Regent, Inc., for this generic product.
-
FDA approval · 2012-03-20FDA Approved: OLANZAPINE — Original Application (American Regent, Inc.)
FDA approves American Regent's original-application generic olanzapine product (olanzapine) for distribution in the United States.
-
CLINICAL_TRIALS research · 2012-03-19Clinical Trial Update: Lamictal Bipolar Observational Study
The document reports that an observational clinical trial evaluating Lamictal (lamotrigine) for bipolar disorder has been completed.
-
FDA approval · 2012-03-15FDA Approved: LAMOTRIGINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for lamotrigine from Dr. Reddy's Laboratories Limited. The approval concerns the generic lamotri…
-
FDA approval · 2012-03-15FDA Approved: LAMOTRIGINE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for Lamotrigine from Alembic Pharmaceuticals Limited, sanctioning an updated approval for the ge…
-
FDA approval · 2012-03-15FDA Approved: DIVALPROEX SODIUM — Original Application (Dr. Reddy's Laboratories Ltd)
The FDA approved Dr. Reddy's Laboratories' original application for divalproex sodium, a generic anticonvulsant, for use in conditions such …
-
FDA approval · 2012-03-14FDA Approved: LAMOTRIGINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Lamotrigine from Sun Pharmaceutical Industries, Inc. The action indicates a labeling update or p…